von Willebrand Factor/Coagulation Factor VIII Complex (Human) (Wilate)
von Willebrand Factor/Coagulation Factor VIII Complex (Human) is an FDA-licensed reference biologic from Octapharma Pharmazeutika Produktionsges.m.b.H.. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2010
Reference approved
Reference product
Wilate von Willebrand Factor/Coagulation Factor VIII Complex (Human)
Octapharma Pharmazeutika Produktionsges.m.b.H.
- Approved
- Dec 20, 2010
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for von Willebrand Factor/Coagulation Factor VIII Complex (Human), in chronological order.
Reference approval
Approval date of the reference von Willebrand Factor/Coagulation Factor VIII Complex (Human) product.
15 yr 8 mo ago
Orphan exclusivity ends
7-year orphan-drug exclusivity window.
in 4 yr 7 mo
Frequently asked questions
Are there biosimilars approved for von Willebrand Factor/Coagulation Factor VIII Complex (Human) (Wilate)?
No 351(k) biosimilars or interchangeable biosimilars referencing von Willebrand Factor/Coagulation Factor VIII Complex (Human) are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.